I agree with you. Let me add a few other items to your list"
a) The PIII trial data is worth quite a bit of money, if they sold access to it, after they have mined all of the key findings. So down the road this asset has quite a value.
b) Process patents. This topic has been discussed many times on this board. These are worth quite a sum in this new treatment area.
c) My worst case scenario is that they get the equivalent of an "EUA" for UK and Germany this year. The valuation of this scenario is many multiples of the current share price.
Doc Logic has repeatedly made the overall point you are making as well. Further, the current share price of NWBO is way better than on option since there is no forced end time. Thus, NWBO shares are even better than options at this price.
Finally, I have tried to make the point to the WSB community that NWBO is a much safer BET than GME or going to the casino, since there is deep value associated with the overall DC area of therapy for humans and animals.
Peace.
Dan88 Post:
It seems people are either failed to understand NWBO is a de-risked stock at this market cap with huge upside potential when results are confirmed from TLD/publication;
People seems readily forget scientific evidence and RAs' updated and accommodated policies and support for revised SAP, including better measures of primary and secondary endpoints.
When it comes to a few pennies/dimes shakeup/swing/raid, the solid ground has shaken to the point of knee jerking and insomnia leading to constant whining.
Today's $1.5 is yesterdays' $0.15, and tomorrow's $15 or $30 or even $100 if indeed hundreds of millions of naked short shares exist.
News 
Market Data 
Discover 
AI
